Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Results (Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bandaram Pharma Packtech Ltd has informed the BSE that its Board of Directors will meet on Friday, 30 May 2025 at the registered office. The main agenda is to consider and approve the audited financial statements (both standalone and consolidated) for the quarter and full year ended 31 March 2025, along with the corresponding audit reports. The filing was made on 22 May 2025 by Managing Director Deepak Bandaram under SEBI LODR Regulations 29 and 33. No financial figures, dividend declaration, or other business items are mentioned in this intimation.
This is a routine regulatory intimation ahead of FY25 results. Investors should watch the outcome on 30 May 2025 for the company's full-year and Q4 FY25 numbers, as actual financial performance is not disclosed in this filing.